Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

AAV-mediated gene transfer to synovium: enhancing effects of inflammatory cytokines and proteasome inhibitors

Traister, Russell Scott (2006) AAV-mediated gene transfer to synovium: enhancing effects of inflammatory cytokines and proteasome inhibitors. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

Primary Text

Download (3MB) | Preview


Rheumatoid arthritis (RA) is an autoimmune disease affecting nearly 1% of the population. The joints of RA patients become inflamed and a pannus of synovial tissue invades cartilage and destroys bone. Current treatments, though moderately successful, are often administered systemically and are associated with significant side effects. Local treatment of arthritis by intra-articular injection of gene transfer vectors has the potential to overcome some of the obstacles of other treatment regimens. In particular, adeno-associated virus (AAV) is attractive as a gene transfer vector because it is non-pathogenic in humans, has low immunogenicity and broad tissue tropism, and provides for long-term transgene expression. The primary target of gene transfer in the joint is the fibroblast-like synoviocytes (FLS), which make up part of the pannus of tissue responsible for cartilage and bone destruction. However, FLS are only minimally transduced by AAV and provide only low levels of transgene expression. For local treatment with AAV vectors to be successful, improvement in the transduction of FLS is necessary. Several agents have been shown to increase AAV transduction in other cell types. The specific effect of inflammation and proteasome inhibition on AAV-mediated transgene expression in FLS has not been examined. Here we show that both inflammatory cytokines and the proteasome inhibitor zLLL can increase transgene expression in FLS dramatically. Remarkably, both agents are also able to regulate transgene expression. The cytokines appear to act in part by promoting uncoating of the virus, while proteasome inhibition works by both increasing the nuclear trafficking of the virus and by increasing transcription of the viral DNA. In addtion, we screened 3 serotypes of AAV (2, 2.5, and 5) for their ability to transduce FLS from 4 different species: human, mouse, horse, and rabbit. AAV2 provided the highest transgene expression in human and horse FLS, while AAV2.5 was better suited for mouse and rabbit FLS. These results have implications in the future use of AAV vectors in the treatment of RA.


Social Networking:
Share |


Item Type: University of Pittsburgh ETD
Status: Unpublished
CreatorsEmailPitt UsernameORCID
Traister, Russell Scottrst2@pitt.eduRST2
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee ChairHirsch,
Committee Member Kolls, Jayjay.kolls@chp.eduJKK23
Committee MemberRobbins, Paulprobb@pitt.eduPROBB
Committee MemberMorel, Penelopemorel@pitt.eduMOREL
Committee MemberXiao, Xiaoxiaox@pitt.eduXIAOX
Date: 30 August 2006
Date Type: Completion
Defense Date: 24 August 2006
Approval Date: 30 August 2006
Submission Date: 29 August 2006
Access Restriction: No restriction; Release the ETD for access worldwide immediately.
Institution: University of Pittsburgh
Schools and Programs: School of Medicine > Immunology
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: adeno-associated virus; cytokines; gene therapy; inflammation; proteasome inhibitors; rheumatoid arthritis
Other ID:, etd-08292006-134427
Date Deposited: 10 Nov 2011 20:01
Last Modified: 19 Dec 2016 14:37


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item